Tag
Altered gut microbiota composition and metabolism exacerbate cirrhotic portal hypertension, highlighting potential microbiome-targeted therapies to mitigate disease progression.
The gut-skin axis embodies a bidirectional microbiota-influenced dialogue pivotal for tissue homeostasis and disease. Understanding this interplay reveals innovative approaches to manage inflammatory skin and gut diseases.
Perinatal antibiotic exposure in preterm infants disrupts gut microbiota composition, increasing pathogenic bacteria and reducing beneficial species, with implications for infection risk and the protective role of breastfeeding.
